From: Epidemiological profile of brain tumors in Cameroon: a retrospective study
Variables | Meningioma n (%) | Astrocytoma n (%) | Pituitary adenomas n (%) | Metastasis n (%) | ||
---|---|---|---|---|---|---|
Age range | ||||||
0–14 | 2 (5.13) | 8 (20.51) | – | – | ||
15–24 | – | 5 (13.51) | 5 (18.52) | 1 (8.33) | ||
25–54 | 25 (64.1) | 19 (48.72) | 18 (66.67) | 3 (25) | ||
≥ 55 | 12 (30.77) | 5 (13.51) | 4 (14.81) | 8 (66.67) | ||
Gender | ||||||
Male | 19 (48.72) | 20 (54.05) | 11 (40.74) | 6 (50) | ||
Female | 20 (52.63) | 17 (45.95) | 16 (59.26) | 6 (50) | ||
Histological subtypes | ||||||
WHO Grade I | 25 (64.1) | 11 (29.73) | Prolactinoma | 15 (55.50) | Lung cancer | 6 (50) |
WHO Grade II | 6 (15.38) | 3 (8.11) | Cushing’s disease | 5 (18.6) | Breast cancer | 4 (33.33) |
WHO Grade III | 8 (20.51) | 2 (5.41) | Acromegaly | 4 (14.8) | Hodgkin’s lymphoma | 1 (8.33) |
WHO Grade IV | – | 21 (56.76) | TSH adenoma | 3 (11.1) | Burkitt’s lymphoma | 1 (8.33) |